Elizabeth G. Nabel, MD, the Director of the National Heart, Lung, and Blood Institute of the National Institutes of Health, has been named the next president. Dr. Nabel will assume her position January 1, succeeding Gary Gottlieb, MD, MBA.
Online PR News – 12-November-2009 – – Brigham and Women's/Faulkner Hospitals (BW/F) named Elizabeth G. Nabel, MD, the Director of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, its next president after a unanimous vote last evening by the Board of Trustees. Dr. Nabel, who will assume her position January 1, 2010, will succeed Gary Gottlieb, MD, MBA, who becomes CEO and president of Partners HealthCare when James Mongan, MD, retires at the beginning of the new year.
"We are extremely pleased that Dr. Nabel, an extraordinarily talented and accomplished physician, scientist and educator, is joining the Brigham and Women's/Faulkner community," said Gottlieb. "Her vision to build on the hospitals' legacy of excellence in care, research and teaching will strengthen further a steadfast commitment to our patients, their families and all the communities that we serve."
For Dr. Nabel this is a homecoming. She completed her internship and residency in internal medicine and a clinical and research fellowship in cardiovascular medicine at BWH and Harvard University. Prior to this, she graduated from the Cornell University Medical College.
"The opening of this door is a tremendous opportunity to share a personal passion with world-class clinicians and scientists to link excellent patient care to internationally-respected research and then carry our collective wisdom forward to our students, the future leaders of medicine," according to Dr. Nabel. "All of this will be done with a keen focus on how we can make a difference in the lives of those who depend on us whether they live half way around the world or across the street from our front doors."
During her distinguished career, she has served on the faculty at the University of Michigan, joining in 1987 as an Assistant Professor of Medicine. She went on to become Director of the Cardiovascular Research Center, Professor of Internal Medicine and Physiology, and then Chief of the Division of Cardiology. She is a board-certified cardiologist.
While at the University of Michigan, Dr. Nabel became known for her research in the fields of vascular biology and molecular cardiology and with her gene transfer studies of the cardiovascular system. In 1999, she joined the NHLBI as Scientific Director for Clinical Research and in 2005 became Director, where she oversees an extensive national research portfolio and an annual budget of approximately $3 billion.
At the NHLBI, she is active in community outreach programs, believing strongly in the need to bring attention to important research findings that can touch and improve lives, with a particular focus on women and heart disease, such as the Red Dress campaign and through the childhood obesity program known as WE CAN.
Dr. Nabel is a nationally recognized scholar; working with her NIH Vascular Biology Lab, she is the author of 250 publications. Her numerous honors and awards affirm the depth and breadth of her dedication to medicine, including her commitment to mentoring the next generation. Her colleagues have recognized her leadership by selecting her to the American Academy of Arts and Sciences, the Association of American Physicians (Council), the Institute of Medicine of the National Academy of Sciences (Council), and as a Fellow of the American Association for the Advancement of Science. Dr. Nabel currently serves on the Editorial Boards of the New England Journal of Medicine and Science Translational Medicine.
Dr. Nabel is a native of St. Paul, Minnesota, but her ties to Boston run deep. Not only did she train at Brigham and Women's, but she and her husband Gary J. Nabel, MD, PhD, met during their residencies at the hospital. They have three children, Christopher, 23, Elisa, 21, and Katherine, 17.
"The Board members of Brigham and Women's/Faulkner Hospitals enthusiastically welcome Dr. Nabel and her family to the BW/F community and to the Partners HealthCare system," said George Marshall Moriarty, Esq, Chairman of the BW/F Board of Trustees. "Her leadership, her passion and her collaborative spirit will allow our clinicians, our scientists and our next generation of providers to continue to grow and build on the foundation of excellence that is a hallmark of the BW/F hospitals."
About Brigham and Women's Hospital:-
Brigham and Women's Hospital (BWH) is a 777-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. In July of 2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty supported by more than $416 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit http://www.brighamandwomens.org/